Gilead Sciences | 8-K: Gilead Sciences Announces Completion of Acquisition of CymaBay Therapeutics and Enters into an Agreement and Plan of Merger with Wholly-Owned Subsidiary Pacific Merger Sub
Gilead Sciences | 8-K: Gilead Sciences Announces Completion of Acquisition of CymaBay Therapeutics and Enters into an Agreement and Plan of Merger with Wholly-Owned Subsidiary Pacific Merger Sub
吉利德科学 | 8-K：Gilead Sciences宣布完成对CymaBay Therapeutics的收购并与全资子公司Pacific Merger Sub签订了一份协议和合并计划
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。